Skip to Main Content

Paper Details

A Liquid Biopsy to Assess Brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish Brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.
Neurosurgery
6
2020
BM, Brain Tumor, Brain metastases, CD14, CD14+, CD14+ HLA-DRneg/low Mo-MDSC, CD14+ VNN2+ Myeloid Cells, CD14+ monocytes, HLA-DRneg, HLA-Dr, Mo-MDSC, Monocytic Myeloid, Monocytic Myeloid-Derived Suppressor Cells, Necrosis, RN, VNN2, Vnn2, blood sample, brain metastasis, brain tumor malignancy, cancer, circulating, patients, radiation necrosis
Author NameAffiliation
Jill S Barnholtz-SloanCase Western Reserve University School of Medicine
Jill S Barnholtz-SloanBrain Tumor and Neuro-Oncology Center, Case Western Reserve University School of Medicine
Jill S Barnholtz-SloanUniversity Hospitals-Cleveland Medical Center and the Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Jill S Barnholtz-SloanCase Western Reserve University School of Medicine
Jill S Barnholtz-SloanBrain Tumor and Neuro-Oncology Center, Case Western Reserve University School of Medicine
Jill S Barnholtz-SloanUniversity Hospitals-Cleveland Medical Center and the Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine
Andrew E SloanCase Western Reserve University School of Medicine
Andrew E SloanBrain Tumor and Neuro-Oncology Center, Case Western Reserve University School of Medicine
Andrew E SloanUniversity Hospitals-Cleveland Medical Center and the Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine
  • 1 - 9

Datasets

Release 1.2